BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report) has received an average recommendation of “Moderate Buy” from the fifteen analysts that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $19.42.
Several equities research analysts recently weighed in on BTSG shares. Mizuho increased their target price on shares of BrightSpring Health Services from $17.00 to $20.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. CJS Securities initiated coverage on BrightSpring Health Services in a report on Thursday, December 12th. They set an “outperform” rating and a $27.00 price objective on the stock. Wells Fargo & Company boosted their price objective on BrightSpring Health Services from $17.00 to $21.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. Morgan Stanley raised their target price on BrightSpring Health Services from $19.00 to $20.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 17th. Finally, UBS Group boosted their price target on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a “buy” rating in a report on Wednesday, January 29th.
Read Our Latest Stock Analysis on BTSG
BrightSpring Health Services Price Performance
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. L & S Advisors Inc bought a new position in BrightSpring Health Services in the 3rd quarter valued at $1,247,000. Virtu Financial LLC bought a new position in shares of BrightSpring Health Services in the third quarter valued at about $522,000. Assenagon Asset Management S.A. acquired a new position in BrightSpring Health Services during the 3rd quarter worth about $1,822,000. LMR Partners LLP bought a new stake in BrightSpring Health Services during the 3rd quarter worth about $493,000. Finally, JPMorgan Chase & Co. grew its holdings in BrightSpring Health Services by 275.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 163,618 shares of the company’s stock worth $2,402,000 after acquiring an additional 120,005 shares during the last quarter.
About BrightSpring Health Services
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Further Reading
- Five stocks we like better than BrightSpring Health Services
- Basic Materials Stocks Investing
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Most Volatile Stocks, What Investors Need to Know
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Effectively Use the MarketBeat Ratings Screener
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.